Single-domain antibodies for biomedical applications

Simon Krah1, Christian Schröter1, Stefan Zielonka2

  • 1a Protein Engineering and Antibody Technologies , Merck-Serono, Merck KGaA, Darmstadt , Germany .

Summary

Single-domain antibodies, the smallest antigen-binding units, offer high affinity and specificity. These versatile molecules derived from camelids, sharks, or engineered human domains show promise in biomedical applications and clinical development.